22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E 2 Activation in Human Podocytes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glomerular hyperfiltration is an important mechanism in the development of albuminuria. During hyperfiltration, podocytes are exposed to increased fluid flow shear stress (FFSS) in Bowman’s space. Elevated Prostaglandin E2 (PGE 2) synthesis and upregulated cyclooxygenase 2 (Cox2) are associated with podocyte injury by FFSS. We aimed to elucidate a PGE 2 autocrine/paracrine pathway in human podocytes (hPC). We developed a modified liquid chromatography tandem mass spectrometry (LC/ESI-MS/MS) protocol to quantify cellular PGE 2, 15-keto-PGE 2, and 13,14-dihydro-15-keto-PGE 2 levels. hPC were treated with PGE 2 with or without separate or combined blockade of prostaglandin E receptors (EP), EP2, and EP4. Furthermore, the effect of FFSS on COX2, PTGER2, and PTGER4 expression in hPC was quantified. In hPC, stimulation with PGE 2 led to an EP2- and EP4-dependent increase in cyclic adenosine monophosphate (cAMP) and COX2, and induced cellular PGE 2. PTGER4 was downregulated after PGE 2 stimulation in hPC. In the corresponding LC/ESI-MS/MS in vivo analysis at the tissue level, increased PGE 2 and 15-keto-PGE 2 levels were observed in isolated glomeruli obtained from a well-established rat model with glomerular hyperfiltration, the Munich Wistar Frömter rat. COX2 and PTGER2 were upregulated by FFSS. Our data thus support an autocrine/paracrine COX2/PGE 2 pathway in hPC linked to concerted EP2 and EP4 signaling.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: not found

          Prostanoid receptors: structures, properties, and functions.

          Prostanoids are the cyclooxygenase metabolites of arachidonic acid and include prostaglandin (PG) D(2), PGE(2), PGF(2alpha), PGI(2), and thromboxne A(2). They are synthesized and released upon cell stimulation and act on cells in the vicinity of their synthesis to exert their actions. Receptors mediating the actions of prostanoids were recently identified and cloned. They are G protein-coupled receptors with seven transmembrane domains. There are eight types and subtypes of prostanoid receptors that are encoded by different genes but as a whole constitute a subfamily in the superfamily of the rhodopsin-type receptors. Each of the receptors was expressed in cultured cells, and its ligand-binding properties and signal transduction pathways were characterized. Moreover, domains and amino acid residues conferring the specificities of ligand binding and signal transduction are being clarified. Information also is accumulating as to the distribution of these receptors in the body. It is also becoming clear for some types of receptors how expression of their genes is regulated. Furthermore, the gene for each of the eight types of prostanoid receptor has been disrupted, and mice deficient in each type of receptor are being examined to identify and assess the roles played by each receptor under various physiological and pathophysiological conditions. In this article, we summarize these findings and attempt to give an overview of the current status of research on the prostanoid receptors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The hyperfiltration theory: a paradigm shift in nephrology.

            Experimental studies incriminate glomerular hypertension in mediating progressive renal damage after any of a variety of initiating injuries. Prevention of glomerular hypertension by dietary protein restriction or antihypertensive therapy lessens progressive glomerular damage in several experimental models of chronic renal disease. Glomerular hypertension and hyperfiltration also occur in humans with diabetes mellitus, solitary or remnant kidneys, and various forms of acquired renal disease. Clinical studies indicate that dietary protein restriction and antihypertensive therapy also slow progression in many of these disorders. Large multicenter trials confirm the beneficial effects of these therapeutic maneuvers on the rate of progression of chronic renal disease.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Arachidonic acid metabolism.

                Bookmark

                Author and article information

                Journal
                Cells
                Cells
                cells
                Cells
                MDPI
                2073-4409
                19 May 2020
                May 2020
                : 9
                : 5
                : 1256
                Affiliations
                [1 ]Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Charitéplatz 1, 10117 Berlin, Germany; eva.mangelsen@ 123456charite.de (E.M.); angela-martina.schulz@ 123456charite.de (A.S.); reinhold.kreutz@ 123456charite.de (R.K.)
                [2 ]Lipidomix GmbH, Robert-Rössle-Str. 10, B55, 13125 Berlin, Germany; michael.rothe@ 123456lipidomix.de
                [3 ]Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Electrochemical Signaling in Development and Disease, Robert-Rössle-Str. 10, 13125 Berlin, Germany; Aikaterini.Kourpa@ 123456mdc-berlin.de (A.K.); Daniela.Panakova@ 123456mdc-berlin.de (D.P.)
                [4 ]DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Potsdamer Straße 58, 10785 Berlin, Germany
                Author notes
                [* ]Correspondence: juliane.bolbrinker@ 123456charite.de ; Tel.: +49-30-450-525-225
                Author information
                https://orcid.org/0000-0003-2418-8805
                https://orcid.org/0000-0002-4576-8035
                https://orcid.org/0000-0002-0812-8549
                Article
                cells-09-01256
                10.3390/cells9051256
                7290667
                32438662
                fe5a15c3-1eb1-4205-862d-e3a1bb2349c9
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 31 March 2020
                : 14 May 2020
                Categories
                Article

                podocyte,hyperfiltration,chronic kidney disease,prostaglandin e2,cox2,ep2,ep4,g protein-coupled receptor (gpcr) signaling,lc/esi-ms/ms,mwf,shr

                Comments

                Comment on this article